United States

Eli Lilly and Company LLY

NYSE Health technology USD

Eli Lilly and Company is a global pharmaceutical corporation that discovers, develops, manufactures, and markets a wide range of medicines. The company operates across several major therapeutic areas, including Cardiometabolic Health (with products for diabetes, obesity, and cardiovascular conditions), Oncology (cancer treatments), Immunology (treatments for autoimmune diseases), and Neuroscience (medicines for migraine, Alzheimer's disease, and other neurological disorders). It serves patients, healthcare providers, and healthcare systems worldwide through a business model centered on innovative drug research, clinical development, regulatory approval, and global commercialization. The company also engages in strategic collaborations and partnerships to enhance its product portfolio and expand its market reach.

Current Price USD 982.22
Daily Change -1.54%
Market Cap USD 928.57 B
Shares Outstanding 945.38 M
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart